Biote Corp (BTMD)
7.47
+0.08
(+1.08%)
USD |
NASDAQ |
Jun 28, 16:00
7.49
+0.02
(+0.27%)
After-Hours: 20:00
Biote Cash from Financing (Quarterly): -5.409M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.409M |
| December 31, 2023 | -2.525M |
| September 30, 2023 | -2.562M |
| June 30, 2023 | -5.058M |
| March 31, 2023 | -4.235M |
| Date | Value |
|---|---|
| December 31, 2022 | -3.976M |
| September 30, 2022 | -11.26M |
| June 30, 2022 | 84.26M |
| March 31, 2022 | -5.562M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-11.26M
Minimum
Sep 2022
84.26M
Maximum
Jun 2022
4.852M
Average
-4.235M
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| American Shared Hospital Services | 2.282M |
| Novo Integrated Sciences Inc | 0.0032M |
| Astrana Health Inc | 106.35M |
| Cryo-Cell International Inc | 0.539M |
| P3 Health Partners Inc | 11.40M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.372M |
| Cash from Investing (Quarterly) | -12.18M |
| Free Cash Flow | 17.88M |
| Free Cash Flow Per Share (Quarterly) | 0.1825 |
| Free Cash Flow to Equity (Quarterly) | 7.678M |
| Free Cash Flow to Firm (Quarterly) | 9.220M |
| Free Cash Flow Yield | 7.95% |